Navigation Links
deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
Date:2/2/2009

deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE is offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProstateCancer(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer(TM), for the common forms of breast cancer. deCODE is delivering on the promise of the new genetics (SM). Visit us on the web at http://www.decode.com; on our diagnostics site at http://www.decodediagnostics.com; for our pioneering personal genome analysis service and new Cardio and Cancer scans, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at http://www.decodeme.com; and on our blog at http://www.decodeyou.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, the effect of a potential delisting of our common stock from The Nasdaq Global Market, uncertainty regarding potential future deterioration in the market for auction rate securities which could negatively affect our cash position and result in additional permanent impairment c
'/>"/>

SOURCE DeCODE Genetics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. deCODE Sells Auction Rate Securities
2. Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
3. deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
4. deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service
5. Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
6. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
7. deCODE genetics Announces Third Quarter 2008 Financial Results
8. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
9. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
10. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
11. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... In ... billion in 2013; while production volume reached close to 1.84 million tonnes in ... a share of 75.5% of the region’s total aluminium hydroxide production; the country’s ...
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new ... The tour and course will be given every Wednesday at 6pm to local interested ... members are welcome to attend with their veterinarian as well. Participants will be able ...
(Date:7/28/2015)... 2015  Kerastem Technologies announce that the Company has ... Center For Biologics Evaluation and Research (CBER) Office of ... trial investigating the safety and feasibility of the Company,s ... pattern baldness (androgenic alopecia). The phase II ... work in Europe and ...
(Date:7/28/2015)... 28, 2015 CSL Behring announced ... accepted for review the company,s Biologics License Application (BLA) ... for the treatment of hemophilia A. In the pivotal ... Hemophilia A is a congenital bleeding ... all affected patients are male. People with hemophilia A ...
Breaking Biology Technology:EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... Biopharma Corporation,(TSX: OBP; AIM: OBP), a medical ... its Chief Technology,Officer, Dr. Nicolas Loebel, is ... Adams Global Growth Conference at the Intercontinental ... at 1:00 p.m. Eastern Time., Interested ...
... company enabling applications for the real world, ... Methode Electronics, Inc. One of the many ... a solid Tier 1 automotive supplier focusing ... Together, Methode and Lumidigm will bring patented ...
... business of discovery and safety services to, ... and development community, BOSTON and CLEVELAND, Aug. ... channel-expressing cell lines and,services for drug-discovery and development ... cell lines available to researchers,through a new Web ...
Cached Biology Technology:Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference 2 Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 3
(Date:7/23/2015)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended June 30, 2015.  Revenue for ... of 33% compared to $6.8 million in the same quarter ... was $0.3 million, or $0.01 per diluted share, which compared ... same period a year ago.  Lower revenue ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... Calif. , July 9, 2015  Unchained ... today announcing its acquisition of Avid Nano. Avid ... light scattering (DLS) systems.    Also ... smallest, fastest and easiest to use protein sizing ... that measures a protein,s hydrodynamic size, size distribution, ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... The Genetics Society of America (GSA) will host ... Meeting, on June 12 to 15, 2010, in Boston, ... will bring together investigators who study genetic disease models ... other non-human organisms, combined with researchers in human genetics. ...
... discovered a way to "trick" the bacterium that causes anthrax ... body,s immune system to mount a defense. The study, which ... , could lead to new approaches for treating anthrax infection. ... is particularly lethal because of its protective coating, or capsule, ...
... ANN ARBOR, Mich. Prostate cancer treatments that target the ... wrong source, according to a new study. Researchers have found ... it blocks the receptor for the hormone androgen, preventing prostate ... University of Michigan Comprehensive Cancer Center, suggests that the gene ...
Cached Biology News:Genetics Society of America to host Model Organisms to Human Biology Meeting, June 12-15, 2010 2Genetics Society of America to host Model Organisms to Human Biology Meeting, June 12-15, 2010 3Overcoming anthrax bacterium's natural defenses could hold key to new treatments 2Gene fusions may be the 'smoking gun' in prostate cancer development, U-M study finds 2
... II RNA gel stain is a sensitive ... when bound to RNA and low background in ... formaldehyde/agarose or polyacrylamide gels using laser scanners or ... A 500 µL unit size (S-7564) and a ...
... your specific applications and built on the ... Thousands of customer specified sequences can be ... assistance with custom sequence design. These microarrays ... Custom DNA Microarray Service. Paraflo ...
... Microarrays designed for DNA aptamer screening ... flexible and powerful Paraflo microfluidic on-chip synthesis ... of our comprehensive DNA/RNA Aptamer Microarray Service. ... DNA Aptamer Microarray contains greater than 1500 ...
... Microarrays designed for DNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... synthesized on-chip and LC Sciences can provide ... are available as part of our comprehensive ...
Biology Products: